TFFP - TFF Pharmaceuticals Inc. (TFFP) CEO Glenn Mattes on Q4 2021 Results - Earnings Call Transcript

TFF Pharmaceuticals, Inc. (TFFP) Q4 2021 Earnings Conference Call March 24, 2022, 04:30 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President and CEO Dale Christensen - Director of Clinical Development Bill Williams - University of Texas, Austin Kirk Coleman - CFO Chris Cano - COO Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Daniel Carlson - TW Research Group Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals Fourth Quarter and Year-End 2021 Financial Results Conference Call. [Operator Instructions] I would now like to turn the call over to your host, Corey Davis of LifeSci Advisors. You may begin your conference at this time. Corey Davis Thank you, operator. Hello, everyone, and welcome to the TFF Pharmaceuticals fourth quarter and year-end '21 financial and business results conference call. With me on the line today is Glenn Mattes, President and CEO

For further details see:

TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q4 2021 Results - Earnings Call Transcript